Trials / Conditions / Moderate to Severe Rheumatoid Arthritis
Moderate to Severe Rheumatoid Arthritis
6 registered clinical trials studyying Moderate to Severe Rheumatoid Arthritis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therap NCT07008846 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 3 |
| Recruiting | A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING NCT06712628 | AbbVie | — |
| Unknown | A Study to Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumati NCT06306339 | ImmuneMed, Inc. | Phase 2 |
| Completed | MSB11022 in Moderate to Severe Rheumatoid Arthritis NCT03052322 | Fresenius Kabi SwissBioSim GmbH | Phase 3 |
| Terminated | Evaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to A NCT01927757 | Amgen | Phase 4 |
| Completed | Real Life Evaluation of Rheumatoid Arthritis in Canadians Taking HUMIRA NCT01117480 | AbbVie (prior sponsor, Abbott) | — |